Journal of Modern Oncology
ISSN 1815-1434 (Print)
ISSN 1815-1442 (Online)
⽬录
过刊浏览
首页
关于期刊
编辑政策
作者指南
关于期刊
刊期
检索
最新一期
过刊浏览
联系方式
Editorial board
OmniDoctor
所有期刊
用户
用户名
密码
记住我
忘记您的密码?
注册
期刊内容
检索
搜索范围
全部
作者
标题
摘要
索引项目
全文
浏览
通过刊期
通过作者
根据标题
其他杂志
×
用户
用户名
密码
记住我
忘记您的密码?
注册
期刊内容
检索
搜索范围
全部
作者
标题
摘要
索引项目
全文
浏览
通过刊期
通过作者
根据标题
其他杂志
首页
>
检索
>
作者的详细信息
作者的详细信息
Bolotina, Larisa V.
期
栏目
标题
文件
卷 22, 编号 4 (2020)
CLINICAL ONCOLOGY
Differentiated thyroid cancer
(Rus)
卷 23, 编号 1 (2021)
CLINICAL ONCOLOGY
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice
(Rus)
(Eng)
卷 23, 编号 2 (2021)
CLINICAL ONCOLOGY
Prostate cancer
(Rus)
卷 23, 编号 4 (2021)
CLINICAL ONCOLOGY
Gastric cancer: Russian clinical guidelines
(Rus)
卷 24, 编号 4 (2022)
CLINICAL ONCOLOGY
Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study
(Rus)
卷 25, 编号 3 (2023)
CLINICAL ONCOLOGY
Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors”
(Rus)
卷 26, 编号 1 (2024)
Articles
Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia
(Rus)
卷 26, 编号 1 (2024)
Articles
Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study
(Rus)
##common.cookie##
TOP